Chemoinformaics analysis of 3,4,7-trimethylcoumarin
| Molecular Weight | 188.226 | nRot | 0 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 12 |
| Exact Molecular Weight | 188.084 | nRing | 2 |
| Solubility: LogS | -4.488 | nHRing | 1 |
| Solubility: LogP | 3.132 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 29.6455 |
| nHD | 0 | BPOL | 14.6425 |
| QED | 0.595 |
| Synth | 1.955 |
| Natural Product Likeliness | -0.248 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.983 |
| HIA | 0.004 |
| CACO-2 | -4.642 |
| MDCK | 0.0000266 |
| BBB | 0.115 |
| PPB | 0.946299 |
| VDSS | 0.698 |
| FU | 0.0273796 |
| CYP1A2-inh | 0.956 |
| CYP1A2-sub | 0.95 |
| CYP2c19-inh | 0.808 |
| CYP2c19-sub | 0.818 |
| CYP2c9-inh | 0.423 |
| CYP2c9-sub | 0.847 |
| CYP2d6-inh | 0.092 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0.18 |
| CYP3a4-sub | 0.365 |
| CL | 3.085 |
| T12 | 0.213 |
| hERG | 0.049 |
| Ames | 0.046 |
| ROA | 0.074 |
| SkinSen | 0.432 |
| Carcinogencity | 0.663 |
| EI | 0.99 |
| Respiratory | 0.038 |
| NR-Aromatase | 0.159 |
| Antiviral | No |
| Prediction | 0.673954 |